Veri MedTech (VRHI) files eighth S-1 amendment, sets $15 million Nasdaq IPO
As seen on the 24/7 Wall St. homepage on September 22, 2026.
Amendment No. 8 sets a 3.75 million-share, $15 million Nasdaq IPO
Veri MedTech is eight amendments deep on its S-1, now locking in 3.75 million shares for a $15 million Nasdaq listing with Network 1 Financial Securities running the book. Amendment No. 8 usually means terms are close to final, so the pricing window is the next thing to watch on this micro-cap medtech debut.
Continue ReadingShow less
Veri MedTech Holdings has filed its eighth amendment to its S-1 registration statement, a milestone that typically signals a deal is approaching its final shape. The company is targeting a $15 million raise through 3.75 million shares on Nasdaq, with Network 1 Financial Securities running the book.
Eight amendments is a meaningful number in the IPO process. Each revision narrows the gap between the company and the SEC's sign-off, and by this stage issuers have generally resolved the bulk of regulatory comments, leaving pricing as the primary remaining variable.
Sponsored
For a micro-cap medtech debut of this size, the bookrunner's ability to place shares efficiently matters considerably. Network 1 Financial Securities specializes in smaller offerings, so investor interest at the institutional and high-net-worth level will determine how cleanly the deal prices and where the stock opens.
The next concrete event to track is the pricing window, when the final offer price per share is set ahead of the stock's debut.